$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Controlled sustained release tablets containing bupropion 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/22
출원번호 US-0105447 (1993-08-12)
우선권정보 GB-0017295 (1992-08-14)
발명자 / 주소
  • Ludwig Jennie Sue G. (Greenville NC) Bass
  • Jr. William L. (Farmville NC) Sutton
  • Jr. Joel E. (Greenville NC)
출원인 / 주소
  • Burroughs Wellcome Co. (Research Triangle Park NC 02)
인용정보 피인용 횟수 : 104  인용 특허 : 0

초록

A controlled sustained release tablet having at least one year shelf life and containing bupropion hydrochloride, hydroxypropyl methylcellulose and cysteine hydrochloride or glycine hydrochloride with the tablet having a surface area to volume ratio to effectively control bupropion hydrochloride rel

대표청구항

A controlled sustained release tablet comprising 25 to 500 mg of bupropion hydrochloride and hydroxypropyl methylcellulose, the amount of hydroxypropyl methylcellulose to one part of bupropion hydrochloride being 0.19 to 1.1 and said tablet having a surface to volume ratio of 3:1 to 25:1 cm-1 and sa

이 특허를 인용한 특허 (104)

  1. Arkenau-Maric, Elisabeth; Bartholomaus, Johannes; Kugelmann, Heinrich, Abuse-proof dosage form.
  2. Arkenau-Maric, Elisabeth; Bartholomaeus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  3. Arkenau-Maric, Elisabeth; Bartholomaeus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  4. Arkenau-Maric, Elisabeth; Bartholomäus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  5. Arkenau-Maric, Elisabeth; Bartholomäus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  6. Bartholomaeus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  7. Bartholomaus, Johannes; Kugelmann, Heinrich; Arkenau-Marić, Elisabeth, Abuse-proofed dosage form.
  8. Bartholomäus, Johannes; Kugelmann, Heinrich; Arkenau-Marić, Elisabeth, Abuse-proofed dosage form.
  9. Bartholomäus, Johannes; Kugelmann, Heinrich; Arkenau-Marić, Elisabeth, Abuse-proofed dosage form.
  10. Midha Kamal K.,BMX ; Junginer Hans E.,NLX ; Hirsh Mark, Apparatus and method for transdermal delivery of bupropion.
  11. Battist Gerald E. (Reston VA) Bogue B. Arlie (Broad Run VA) Myers Garry L. (Reston VA), Apparatus and process for strengthening low density compression dosage units and product therefrom.
  12. Qun Kevin Fang ; Chrisantha Hugh Senanayake ; Paul Grover, Bupropion metabolites and methods of use.
  13. Thomas P. Jerussi ; John R. McCullough ; Chrisantha H. Senanayake ; Qun K. Fang, Bupropion metabolites and methods of use.
  14. Cowley, Michael A.; McKinney, Anthony A.; Tollefson, Gary, Compositions and methods for increasing insulin sensitivity.
  15. Cowley, Michael A.; McKinney, Anthony A.; Tollefson, Gary, Compositions and methods for increasing insulin sensitivity.
  16. Gjorstrup, Per; Schwartz, C. Eric, Compositions and methods for the treatment of inflammation.
  17. Gjorstrup, Per; Schwartz, C. Eric, Compositions and methods for the treatment of inflammation.
  18. Weber, Eckard; Cowley, Michael Alexander, Compositions for affecting weight loss.
  19. Weber,Eckard; Cowley,Michael Alexander, Compositions for affecting weight loss.
  20. Weber,Eckard; Cowley,Michael Alexander, Compositions for affecting weight loss.
  21. Gadde,Kishore M.; Krishnan,K. Ranga R., Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss.
  22. Krishnan, K. Ranga R.; Gadde, Kishore M., Compositions of an anticonvulsant and mirtazapine to prevent weight gain.
  23. Chen Chih-Ming ; Xie Jianbo ; Jan Steve, Controlled release bupropion formulation.
  24. Li, Boyong; Nangia, Avinash; Chen, Chih Ming, Controlled release oral dosage form.
  25. Li, Boyong; Nangia, Avinash; Chen, Chih Ming; Cheng, Xiu Xiu, Controlled release oral dosage form.
  26. Li, Boyong; Nangia, Avinash; Chen, Chih Ming; Cheng, Xiu Xiu, Controlled release oral dosage form.
  27. Li, Boyong; Nangia, Avinash; Chen, Chih Ming; Cheng, Xiu Xiu, Controlled release oral dosage form.
  28. Li, Boyong; Nangia, Avinash; Chen, Chih Ming; Cheng, Xiu Xiu, Controlled release oral dosage form.
  29. Seth Pawan, Controlled release tablet of bupropion hydrochloride.
  30. Zerbe, Horst G.; Paiement, Nadine, Controlled-release pharmaceutical tablets.
  31. Lee, Hun Joo; Lim, Jung Youl; Jung, Yong Woo; Lim, Bum Hyun; Shim, Kwang Hyun; Choi, Jin Sung; Yang, Kwang Ho; Kim, Hyun Bin, Database cache system.
  32. Seth Pawan, Delayed release coated tablet of bupropion hydrochloride.
  33. Seth Pawan, Delayed release tablet of bupropion hydrochloride.
  34. Arkenau-Marić, Elisabeth; Bartholomaeus, Johannes; Ziegler, Iris; Haupts, Marcel, Dosage form with impeded abuse.
  35. Barnscheid, Lutz; Galia, Eric, Hot-melt extruded pharmaceutical dosage form.
  36. Koong, Albert C.; Feldman, Douglas E., Inhibitors of the unfolded protein response and methods for their use.
  37. McKinney, Anthony; Tollefson, Gary; Weber, Eckard; Soltero, Rick, Layered pharmaceutical formulations.
  38. McKinney, Anthony; Tollefson, Gary; Weber, Eckard; Soltero, Rick, Layered pharmaceutical formulations.
  39. Houdi Abdulghani A. ; Hussain Anwar A., Method for enhanced brain delivery of bupropion.
  40. James W. Young, Method for treating depression using optically pure (-)-bupropion.
  41. Gadde, Kishore M.; Krishnan, K. Ranga R., Method for treating obesity.
  42. Gadde,Kishore M.; Krishnan,K. Ranga R., Method for treating obesity.
  43. John R. McCullough ; Paul D. Rubin, Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (+)-bupropion.
  44. John R. McCullough ; Paul D. Rubin, Methods and compositions for treating chronic disorders using optically pure (+)-bupropion.
  45. Kumar Vijai ; McGuffy Kevin Scott, Methods and formulations for making bupropion hydrochloride tablets using direct compression.
  46. Chow, San-Laung; Wong, David; Garcia, Damian, Methods and formulations for making pharmaceutical compositions containing bupropion.
  47. McKinney, Anthony A.; Tollefson, Gary; Weber, Eckard; Soltero, Rick, Methods for administering weight loss medications.
  48. McKinney, Anthony; Tollefson, Gary; Weber, Eckard; Soltero, Rick, Methods for administering weight loss medications.
  49. Young James W., Methods for treating Parkinson's disease using optically pure (-)-bupropion.
  50. James W. Young, Methods for treating depression and other disorders using optically pure (-)-bupropion.
  51. Young James W., Methods for treating obesity and weight gain using optically pure (-)-bupropion.
  52. Dunayevich, Eduardo; Tollefson, Gary, Methods of providing weight loss therapy in patients with major depression.
  53. Jonas, Jeffrey; Bose, Anjana; Tsai, Joyce, Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion.
  54. Klassen, Preston; Taylor, Kristin, Methods of treating overweight and obesity.
  55. Wennogle, Lawrence P., Methods of treating vasomotor symptoms.
  56. Oberegger, Werner; Maes, Paul; Jackson, Graham; Saleh, Mohammad Ashty, Modified release formulations of a bupropion salt.
  57. Oberegger, Werner; Maes, Paul; Saleh, Mohammad Ashty, Modified release formulations of a bupropion salt.
  58. Oberegger, Werner; Zhou, Fang; Maes, Paul; Jackson, Graham; Saleh, Mohammad Ashty, Modified release formulations of a bupropion salt.
  59. Oberegger, Werner; Zhou, Fang; Maes, Paul; Jackson, Graham; Saleh, Mohammad Ashty, Modified release formulations of a bupropion salt.
  60. Oberegger, Werner; Zhou, Fang; Maes, Paul; Turchetta, Stefano; Jackson, Graham; Massardo, Pietro; Saleh, Mohammad Ashty, Modified release formulations of a bupropion salt.
  61. Oberegger,Werner; Zhou,Fang; Maes,Paul; Turchetta,Stefano; Jackson,Graham; Massardo,Pietro; Saleh,Mohammad Ashty, Modified release formulations of a bupropion salt.
  62. Oberegger, Werner; Eradiri, Okponanabofa; Zhou, Fang; Maes, Paul, Modified release tablet of bupropion hydrochloride.
  63. Oberegger, Werner; Zhou, Fang; Maes, Paul; Turchetta, Stefano; Jackson, Graham; Massardo, Pietro; Saleh, Mohammad Ashty, Modified-release formulations of a bupropion salt.
  64. Barnscheid, Lutz; Wening, Klaus; Pätz, Jana; Geissler, Anja, Multiparticles safeguarded against ethanolic dose-dumping.
  65. Barnscheid, Lutz; Galia, Eric; Schwier, Sebastian; Bertram, Ulrike; Geissler, Anja; Griessmann, Kornelia; Bartholomäus, Johannes, Oxidation-stabilized tamper-resistant dosage form.
  66. Kulkarni Prakash Shriram ; Shah Bharat Bhogilal ; Maitra Amitava ; DeVito Joseph Michael, Pharmaceutical composition containing bupropion hydrochloride and a stabilizer.
  67. Maitra Amitava ; Kulkarni Prakash Shriram ; Shah Bharat Bhogilal ; DeVito Joseph Michael, Pharmaceutical composition containing bupropion hydrochloride and a stabilizer.
  68. Prakash Shriram Kulkarni ; Bharat Bhogilal Shah ; Amitava Maitra ; Joseph Michael DeVito, Pharmaceutical composition containing bupropion hydrochloride and a stabilizer.
  69. Maitra Amitava ; Kulkarni Prakash Shriram ; Shah Bharat Bhogilal ; DeVito Joseph Michael, Pharmaceutical composition containing bupropion hydrochloride and an inorganic acid stabilizer.
  70. Jans, Eugeen Marie Jozef; Kiekens, Filip René Irena; Voorspoels, Jody Firmin Marceline; Faure, Anne; Arkenau-Maric, Elisabeth; Barnscheid, Lutz; Bartholomäus, Johannes; Frevel, Marc; Galia, Eric; Ziegler, Iris; Schüssele, Andrea, Pharmaceutical dosage form.
  71. Jans, Eugeen Marie Jozef; Kiekens, Filip René Irena; Voorspoels, Jody Firmin Marceline; Faure, Anne; Ziegler, Iris; Arkenau-Maric, Elisabeth; Barnscheid, Lutz; Bartholomäus, Johannes; Frevel, Marc; Galia, Eric; Schüessele, Andrea, Pharmaceutical dosage form.
  72. Ascher,John A.; Johnston,Joseph Andrews; Learned Coughlin,Susan Marie; Bye,Alan, Pharmaceutically active morpholinol.
  73. Broom, Toby; Delpogetto, Monica; Atkins, Richard; Negus, Alan; Oxley, Paul William, Pharmaceutically active morpholinol.
  74. Musso,David Lee, Pharmaceutically active morpholinol.
  75. Partridge, John Joseph, Pharmaceutically active morpholinol.
  76. Markey,Micheline; Shell,John W.; Berner,Bret, Pharmacological inducement of the fed mode for enhanced drug administration to the stomach.
  77. Haupts, Marcel, Preparation of a powdery pharmaceutical composition by means of an extruder.
  78. Faure, Anne; Voorspoels, Jody Firim Marceline; Mertens, Roel Jos M.; Kiekens, Filip René Irena, Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet.
  79. Arkenau, Elisabeth; Bartholomāus, Johannes, Process for the production of an abuse-proofed solid dosage form.
  80. Arkenau-Maric, Elisabeth; Bartholomäus, Johannes; Kugelmann, Heinrich, Process for the production of an abuse-proofed solid dosage form.
  81. Zerbe, Horst; Paiement, Nadine; Angusti, Angela; Long, Cormac, Solid oral film dosage forms and methods for making same.
  82. Shin, Hyeon-Cheol; Hwang, Hyejeong, Solid pharmaceutical compositions of brown algae.
  83. Ruff Michael David ; Kalidindi Sanyasi Raju ; Sutton ; Jr. Joel Elmore, Stabilized pharmaceutical composition containing bupropion.
  84. Apelian Vahe Henry ; Parikh Nilesh H. ; Iyer Raman, Stabilized pharmaceutical compositions.
  85. Chungi Shubha ; Lin Kangwen, Stabilized, acid-free formulation for sustained release of bupropion hydrochloride.
  86. Li, Boyong; Cheng, Xiu Xiu, Stable pharmaceutical compositions without a stabilizer.
  87. Li, Boyong; Cheng, Xiu Xiu, Stable pharmaceutical compositions without a stabilizer.
  88. Giaccia, Amato; Lai, Edwin; Razorenova, Olga; Chan, Denise; Hay, Michael Patrick; Bonnet, Muriel; Sun, Connie; Tabibiazar, Ray; Yuen, Po-wai, Substituted benzamides and their uses.
  89. Giaccia, Amato; Lai, Edwin; Razorenova, Olga; Chan, Denise; Hay, Michael Patrick; Bonnet, Muriel; Sun, Connie; Tabibiazar, Ray; Yuen, Po-wai, Substituted benzamides and their uses.
  90. McKinney, Anthony A.; Tollefson, Gary D.; Soltero, Richard; Dunzo, Thea Elise, Sustained release formulation of naltrexone.
  91. McKinney, Anthony A.; Tollefson, Gary D.; Soltero, Richard; Dunzo, Thea Elise, Sustained release formulation of naltrexone.
  92. Zerbe, Horst G.; Paiement, Nadine, Sustained-release bupropion and bupropion/mecamylamine tablets.
  93. Chen Tzyy-Show H. ; Katdare Ashok V. ; Nyairo Thomas G., Tablet.
  94. Chen Tzyy-Show H. ; Nyairo Thomas G. ; Katdare Ashok V., Tablet.
  95. Chen Tzyy-Show H. ; Nyairo Thomas G. ; Katdare Ashok V., Tablet.
  96. Chen,Tzyy Show H.; Ikeda,Craig B., Tablet.
  97. Barnscheid, Lutz; Schwier, Sebastian; Bartholomäus, Johannes, Tamper resistant dosage form comprising an anionic polymer.
  98. Barnscheid, Lutz; Geiβler, Anja; Wening, Klaus; Strauch, Stefanie; Pätz, Jana; Schwier, Sebastian, Tamper resistant dosage form with bimodal release profile.
  99. Friedrich, Ingo; Fuhrherr, Richard; Möschter, Silke; Wengner, Simone, Tamper resistant immediate release capsule formulation comprising tapentadol.
  100. Barnscheid, Lutz; Redmer, Jessica; Schwier, Sebastian, Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer.
  101. Barnscheid, Lutz; Geiβler, Anja; Wening, Klaus; Pätz, Jana, Tamper-resistant dosage form containing one or more particles.
  102. Wening, Klaus; Geiβler, Anja; Denker, Jana; Barnscheid, Lutz, Tamper-resistant dosage form with immediate release and resistance against solvent extraction.
  103. Schwier, Sebastian; Haupts, Marcel; Barnscheid, Lutz; Pätz, Jana, Tamper-resistant tablet providing immediate drug release.
  104. Barnscheid, Lutz; Galia, Eric; Geißler, Anja; Pätz, Jana; Schwier, Sebastian; Baronsky-Probst, Julia, Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로